Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1.
J Acquir Immune Defic Syndr. 2000 May 1;24(1):1-9. Unique Identifier : AIDSLINE MED/20334000 Tscherning-Casper C; Vodros D; Menu E; Aperia K; Fredriksson R; Dolcini G; Chaouat G; Barre-Sinoussi F; Albert J; Fenyo EM; Microbiology and Tumorbiology Center, Karolinska Institute,; Stockholm, Sweden. charlotte.tscherning@mtc.ki.se
Abstract:
In this study, coreceptor usage of HIV-1 other than subtype B in relation to HIV-1 transmission from mother to child was investigated. Repeated sampling of 42 HIV-1-seropositive, asymptomatic women in Cameroon during the second and third trimesters of pregnancy, at delivery, and 6 months postpartum were performed. Env subtyping was carried out from uncultured peripheral blood mononuclear cells (PBMCs) by heteroduplex mobility assay and, whenever necessary, by DNA sequencing. Virus isolates were tested for coreceptor usage on human cell lines-U87.CD4 and GHOST(3)-engineered to express stably CD4 and the chemokine receptors CCR1, CCR2b, CCR3, CCR5, or CXCR4, or the orphan receptors BOB/gpr15 or Bonzo/STRL33/TYMSTR. Transmission rate was 11.9%. Viruses were predominantly envelope subtype A and used CCR5 as coreceptor and, surprisingly, 4 of 28 (14.2%) isolates from mothers and 1 of 3 isolates from children used the orphan receptor Bonzo as well. In 2 transmitting mothers from whom sequential HIV-1 isolates were available, viral coreceptor usage evolved from CCR5 monotropic to CCR5/Bonzo dual tropic during pregnancy, and in 1 case transmission of this virus could be documented. Our data suggest that evolution of HIV-1 coreceptor usage to dual (or multi-) tropism may occur during pregnancy.
Keywords: JOURNAL ARTICLE Cameroon/EPIDEMIOLOGY Female Follow-Up Studies Human HIV Envelope Protein gp120/GENETICS HIV Seropositivity/DIAGNOSIS/EPIDEMIOLOGY/*VIROLOGY HIV-1/CLASSIFICATION/GENETICS/ISOLATION & PURIF/*METABOLISM Infant Infant, Newborn Pregnancy Pregnancy Complications, Infectious/EPIDEMIOLOGY/*VIROLOGY Receptors, Cytokine/*METABOLISM Receptors, CCR5/*METABOLISM Receptors, HIV/*METABOLISM RNA, Viral/ANALYSIS Support, Non-U.S. Gov't 001030
A00A1058
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from
Elton John AIDS Foundation,
the National Library of Medicine,
and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.
